Your browser doesn't support javascript.
loading
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.
Sunakawa, Yu; Mogushi, Kaoru; Lenz, Heinz-Josef; Zhang, Wu; Tsuji, Akihito; Takahashi, Takehiro; Denda, Tadamichi; Shimada, Ken; Kochi, Mitsugu; Nakamura, Masato; Kotaka, Masahito; Segawa, Yoshihiko; Tanioka, Hiroaki; Negoro, Yuji; Moran, Miriana; Astrow, Stephanie H; Hsiang, Jack; Stephens, Craig; Fujii, Masashi; Ichikawa, Wataru.
Affiliation
  • Sunakawa Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan. y.suna0825@gmail.com.
  • Mogushi K; Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Juntendo University Graduate School, Tokyo, Japan.
  • Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Tsuji A; Department of Clinical Oncology, Kagawa University Faculty of Medicine Cancer Center, Kagawa University Hospital, Kita, Kagawa, Japan.
  • Takahashi T; Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
  • Denda T; Division of Gastroenterology, Chiba Cancer Center, Chuo, Chiba, Japan.
  • Shimada K; Division of Medical Oncology, Department of Internal Medicine, Showa University Koto Toyosu Hospital, Koto, Tokyo, Japan.
  • Kochi M; Department of Digestive Surgery, Nihon University School of Medicine, Itabashi, Tokyo, Japan.
  • Nakamura M; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Nagano, Japan.
  • Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Hyogo, Japan.
  • Segawa Y; Department of Medical Oncology, International Medical Center, Saitama Medical University, Saitama, Hidaka, Japan.
  • Tanioka H; Department of Clinical Oncology, Kawasaki Medical School, Kurashiki City, Okayama, Japan.
  • Negoro Y; Department of Gastroenterology, Kochi Health Sciences Center, Kochi, Japan.
  • Moran M; R&D and Pharmaceutical Services, Cancer Genetics, Inc., Los Angeles, California.
  • Astrow SH; Kite, a Gilead Company, Santa Monica, California.
  • Hsiang J; R&D and Pharmaceutical Services, Cancer Genetics, Inc., Los Angeles, California.
  • Stephens C; R&D and Pharmaceutical Services, Cancer Genetics, Inc., Los Angeles, California.
  • Fujii M; Department of Digestive Surgery, Nihon University School of Medicine, Itabashi, Tokyo, Japan.
  • Ichikawa W; Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
Mol Cancer Ther ; 17(12): 2788-2795, 2018 12.
Article in En | MEDLINE | ID: mdl-30275242
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Genes, Neoplasm / Cetuximab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Genes, Neoplasm / Cetuximab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos